Drug intelligence / Profile preview

BV-GLP1-01

Development stage: Preclinical
Lead developer: Bioventure
Modality: Peptides
Administration: Subcutaneous

Overview

BV-GLP1-01 is a peptide-based glucagon-like peptide-1 receptor (GLP-1R) agonist being developed by Bioventure, a pharmaceutical company based in the United Arab Emirates. As a GLP-1R agonist, it mimics the physiological effects of the incretin hormone GLP-1, which includes stimulating insulin secretion in a glucose-dependent manner, inhibiting glucagon release, and slowing gastric emptying to improve glycemic control in patients with diabetes. Bioventure, a subsidiary of GlobalOne Healthcare Holding (Yas Holding), focuses on the commercialization of biosimilars and specialty therapeutics in the Middle East and North Africa (MENA) region. BV-GLP1-01 is part of their metabolic pipeline, potentially representing a biosimilar or a value-added version of an existing GLP-1 therapy intended for the regional market.

Other names: Bioventure GLP-1 receptor peptide

Targets

GLP1R (GLP-1R)

Beyond the preview

Go deeper on BV-GLP1-01.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BV-GLP1-01.

Explore the full profile